Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, will be hosting the Qatar 8th National Sepsis Symposium on 13 September 2021 in partnership with Hamad Medical Corporation (HMC).

Sepsis is a life-threatening complication and arises when the body’s response to an infection injures its own tissues and organs. It may lead to shock, multi-organ failure, and death, especially if not recognized early and treated promptly.

The Qatar 8th National Sepsis Symposium will bring together national and international healthcare professionals to discuss all aspects of Sepsis, including prevention through vaccines, biomarkers and best practices for treatment. The event, which is in its third year, will be hosted online and in person (by invitation) at Sidra Medicine’s Auditorium.

International speakers at the event include Dr. John Bradley, Distinguished Professor of Infectious Diseases from UC San Diego School of Medicine who will be presenting on the Biomarkers of Sepsis and Dr. Abdulelah Alhawsawi, lead from the Eastern Mediterranean Sepsis Alliance (EMSA).  In addition to experts from Sidra Medicine, speakers from the Ministry of Public Health, the Communicable Disease Center, Hamad Medical Corporation and Primary Health Care Corporation will also present Sepsis programs updates in Qatar.

Dr. Mohammad Janahi, Division Chief of Infectious Diseases and Chair of the Sepsis program at Sidra Medicine: “Sepsis is a global health crisis and according to the World Health Organization, one in every five deaths can be attributed to Sepsis! With 50 million patients affected by Sepsis, many survivors face long term consequences. This is a critical topic and our main goal is to actively engage clinical and scientific expertise to enhance healthcare professionals’ knowledge of early detection and immediate treatment of Sepsis based on global best practices.  We are pleased to partner with Hamad Medical Corporation in continuing our national mission of continually improving Sepsis care and outcomes within the healthcare sector in Qatar.”

The symposium will also seek to address the wide-ranging consequences of Sepsis including evidence-based correlation between COVID-19 and sepsis related deaths.

Dr. Rasha Ashour, Senior Attending Physician at Sidra Medicine, National Pediatric Sepsis Lead and Chair of the Symposium said: “The pandemic has put Sepsis at the forefront as a critical healthcare emergency given that Sepsis remains the main cause of hospital re-admissions and higher healthcare costs. According to the Global Sepsis Alliance and the World Health Organization, Sepsis is the underlying cause of death from most infectious diseases, including COVID-19. The theme “Stop Sepsis, Save Lives” remains relevant today and our experts from Sidra Medicine along with our partners from across the healthcare spectrum in Qatar will be discussing the national efforts to address Sepsis care as well as the impact of COVID-19. We look forward to working together with our colleagues and peers across Qatar in raising awareness and enhancing sepsis care for all patients.”

“Qatar’s Ministry of Public Health has mandated that sepsis care is one of a few significant health challenges being addressed by inter-professional and multi-disciplinary teams working across the public healthcare sector. The National Sepsis Program, which includes representatives from Hamad Medical Corporation, Primary Health Care Corporation and Sidra Medicine, focuses on developing, implementing and monitoring national sepsis management protocols and guidelines to promote high standards of evidenced- based care,” said Dr. Abdul Salam Saif, National Sepsis Program Lead and Head of Medicine Critical Care at HMC.

Qatar is now an official member of the Global Sepsis Alliance, in part through Sidra Medicine’s membership with the Eastern Mediterranean Sepsis Alliance (EMSA).

For details about the Qatar 8th National Sepsis Symposium, please visit: The Qatar 8th National Sepsis Symposium | Sidra Medicine

-Ends-

For media enquiries and interviews contact: pr@sidra.org 

About Sidra Medicine 

Sidra Medicine provides specialized healthcare to women, children, and young people from Qatar and around the world. Established by Qatar Foundation for Education, Science and Community Development, Sidra Medicine embraces best practice medical education, innovative biomedical and clinical research and discovery, and exceptional patient and family focused care.

Sidra Medicine provides comprehensive specialist healthcare services for children and young people, as well as maternity and gynecology care for women. Some of its unique children’s specialist services include Cardiology, Neurology, Urology and Plastics & Craniofacial Reconstruction. It is also currently the only specialist center in the country that treats and cares for pregnant women with fetal complications.

The ultramodern healthcare organization is a testament to Qatar’s pioneering spirit and sustained commitment to its human and social development.

To access Sidra Medicine services, and learn more about our contribution to global healthcare, education and research, please visit www.sidra.org 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.